{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:00:43Z","timestamp":1790992843551,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"foundation for the national institutes of health","doi-asserted-by":"publisher","award":["R01-NS097800"],"award-info":[{"award-number":["R01-NS097800"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12017-021-08687-7","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T06:02:39Z","timestamp":1632117759000},"page":"274-278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Compound 21, a Direct AT2R Agonist, Induces IL-10 and Inhibits Inflammation in Mice Following Traumatic Brain Injury"],"prefix":"10.1007","volume":"24","author":[{"given":"Saifudeen","family":"Ismael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9869-1342","authenticated-orcid":false,"given":"Tauheed","family":"Ishrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"8687_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbr.2017.12.007","volume":"346","author":"HA Ahmed","year":"2018","unstructured":"Ahmed, H. A., Ishrat, T., Pillai, B., Bunting, K. M., Patel, A., Vazdarjanova, A., et al. (2018a). Role of angiotensin system modulation on progression of cognitive impairment and brain MRI changes in aged hypertensive animals\u2014A randomized double- blind pre-clinical study. Behavioural Brain Research, 346, 29\u201340. https:\/\/doi.org\/10.1016\/j.bbr.2017.12.007","journal-title":"Behavioural Brain Research"},{"key":"8687_CR2","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.bbr.2018.10.010","volume":"359","author":"HA Ahmed","year":"2019","unstructured":"Ahmed, H. A., Ishrat, T., Pillai, B., Bunting, K. M., Vazdarjanova, A., Waller, J. L., et al. (2019). Angiotensin receptor (AT2R) agonist C21 prevents cognitive decline after permanent stroke in aged animals\u2014A randomized double-blind pre-clinical study. Behavioural Brain Research, 359, 560\u2013569.","journal-title":"Behavioural Brain Research"},{"issue":"1","key":"8687_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-018-1262-x","volume":"15","author":"HA Ahmed","year":"2018","unstructured":"Ahmed, H. A., Ishrat, T., Pillai, B., Fouda, A. Y., Sayed, M. A., Eldahshan, W., et al. (2018b). RAS modulation prevents progressive cognitive impairment after experimental stroke: a randomized, blinded preclinical trial. Journal of Neuroinflammation, 15(1), 1\u201316.","journal-title":"Journal of Neuroinflammation"},{"issue":"11","key":"8687_CR4","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1089\/neu.2011.2171","volume":"29","author":"AK Au","year":"2012","unstructured":"Au, A. K., Aneja, R. K., Bell, M. J., Bayir, H., Feldman, K., Adelson, P. D., et al. (2012). Cerebrospinal fluid levels of high-mobility group box 1 and cytochrome C predict outcome after pediatric traumatic brain injury. Journal of Neurotrauma, 29(11), 2013\u20132021. https:\/\/doi.org\/10.1089\/neu.2011.2171","journal-title":"Journal of Neurotrauma"},{"issue":"2","key":"8687_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/HTR.0000000000000012","volume":"30","author":"JP Cuthbert","year":"2015","unstructured":"Cuthbert, J. P., Harrison-Felix, C., Corrigan, J. D., Kreider, S., Bell, J. M., Coronado, V. G., et al. (2015). Epidemiology of adults receiving acute inpatient rehabilitation for a primary diagnosis of traumatic brain injury in the United States. The Journal of Head Trauma Rehabilitation, 30(2), 122\u2013135. https:\/\/doi.org\/10.1097\/HTR.0000000000000012","journal-title":"The Journal of Head Trauma Rehabilitation"},{"key":"8687_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejphar.2017.02.016","volume":"799","author":"AY Fouda","year":"2017","unstructured":"Fouda, A. Y., Pillai, B., Dhandapani, K. M., Ergul, A., & Fagan, S. C. (2017). Role of interleukin-10 in the neuroprotective effect of the Angiotensin Type 2 Receptor agonist, compound 21, after ischemia\/reperfusion injury. European Journal of Pharmacology, 799, 128\u2013134. https:\/\/doi.org\/10.1016\/j.ejphar.2017.02.016","journal-title":"European Journal of Pharmacology"},{"key":"8687_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/1742-2094-9-279","volume":"9","author":"AM Fukuda","year":"2012","unstructured":"Fukuda, A. M., & Badaut, J. (2012). Aquaporin 4: A player in cerebral edema and neuroinflammation. Journal of Neuroinflammation, 9, 279. https:\/\/doi.org\/10.1186\/1742-2094-9-279","journal-title":"Journal of Neuroinflammation"},{"key":"8687_CR8","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X18764773","author":"T Ishrat","year":"2018","unstructured":"Ishrat, T., Fouda, A. Y., Pillai, B., Eldahshan, W., Ahmed, H., Waller, J. L., et al. (2018). Dose-response, therapeutic time-window and tPA-combinatorial efficacy of compound 21: A randomized, blinded preclinical trial in a rat model of thromboembolic stroke. Journal of Cerebral Blood Flow & Metabolism. https:\/\/doi.org\/10.1177\/0271678X18764773","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"issue":"11","key":"8687_CR9","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1089\/neu.2017.5344","volume":"35","author":"S Ismael","year":"2018","unstructured":"Ismael, S., Nasoohi, S., & Ishrat, T. J. J. (2018). MCC950, the selective inhibitor of nucleotide oligomerization domain-like receptor protein-3 inflammasome, protects mice against traumatic brain injury. Journal of Neurotrauma, 35(11), 1294\u20131303.","journal-title":"Journal of Neurotrauma"},{"issue":"4","key":"8687_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jash.2015.01.010","volume":"9","author":"J Iwanami","year":"2015","unstructured":"Iwanami, J., Mogi, M., Tsukuda, K., Wang, X. L., Nakaoka, H., Kan-no, H., et al. (2015). Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia. Journal of the American Society of Hypertension, 9(4), 250\u2013256. https:\/\/doi.org\/10.1016\/j.jash.2015.01.010","journal-title":"Journal of the American Society of Hypertension"},{"key":"8687_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030876","author":"L Jackson","year":"2018","unstructured":"Jackson, L., Eldahshan, W., Fagan, S. C., & Ergul, A. (2018). Within the brain: The renin angiotensin system. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms19030876","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"8687_CR12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.4103\/1673-5374.270304","volume":"15","author":"ZC Janatpour","year":"2020","unstructured":"Janatpour, Z. C., & Symes, A. J. (2020). The extended renin-angiotensin system: A promising target for traumatic brain injury therapeutics. Neural Regeneration Research, 15(6), 1025\u20131026. https:\/\/doi.org\/10.4103\/1673-5374.270304","journal-title":"Neural Regeneration Research"},{"key":"8687_CR13","first-page":"1","volume":"1","author":"G Mirzahosseini","year":"2021","unstructured":"Mirzahosseini, G., Ismael, S., Ahmed, H. A., & Ishrat, T. J. M. B. D. (2021). Manifestation of renin angiotensin system modulation in traumatic brain injury. Metabolic Brain Disease, 1, 1\u20138.","journal-title":"Metabolic Brain Disease"},{"key":"8687_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2012.11.008","volume":"51","author":"P Namsolleck","year":"2013","unstructured":"Namsolleck, P., Boato, F., Schwengel, K., Paulis, L., Matho, K. S., Geurts, N., et al. (2013). AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression. Neurobiology of Diseases, 51, 177\u2013191. https:\/\/doi.org\/10.1016\/j.nbd.2012.11.008","journal-title":"Neurobiology of Diseases"},{"key":"8687_CR15","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fnins.2018.00628","volume":"12","author":"YN Paudel","year":"2018","unstructured":"Paudel, Y. N., Shaikh, M. F., Chakraborti, A., Kumari, Y., Aledo-Serrano, A., Aleksovska, K., et al. (2018). HMGB1: A common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction. Frontiers in Neuroscience, 12, 628. https:\/\/doi.org\/10.3389\/fnins.2018.00628","journal-title":"Frontiers in Neuroscience"},{"key":"8687_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jsbmb.2015.11.010","volume":"160","author":"M Schumacher","year":"2016","unstructured":"Schumacher, M., Denier, C., Oudinet, J. P., Adams, D., & Guennoun, R. (2016). Progesterone neuroprotection: The background of clinical trial failure. Journal of Steroid Biochemistry and Molecular Biology, 160, 53\u201366. https:\/\/doi.org\/10.1016\/j.jsbmb.2015.11.010","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"issue":"8","key":"8687_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1179\/016164103771953998","volume":"25","author":"A Tasci","year":"2003","unstructured":"Tasci, A., Okay, O., Gezici, A. R., Ergun, R., & Ergungor, F. (2003). Prognostic value of interleukin-1 beta levels after acute brain injury. Neurological Research, 25(8), 871\u2013874. https:\/\/doi.org\/10.1179\/016164103771953998","journal-title":"Neurological Research"},{"issue":"4","key":"8687_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11596-016-1628-1","volume":"36","author":"X Wei","year":"2016","unstructured":"Wei, X., Hu, C. C., Zhang, Y. L., Yao, S. L., & Mao, W. K. (2016). Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury. Journal of Huazhong University of Science and Technology. Medical Sciences, 36(4), 576\u2013583. https:\/\/doi.org\/10.1007\/s11596-016-1628-1","journal-title":"Journal of Huazhong University of Science and Technology. Medical Sciences"},{"issue":"10","key":"8687_CR19","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","volume":"81","author":"S Yasar","year":"2013","unstructured":"Yasar, S., Xia, J., Yao, W., Furberg, C. D., Xue, Q. L., Mercado, C. I., et al. (2013). Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology, 81(10), 896\u2013903. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a35228","journal-title":"Neurology"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-021-08687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12017-021-08687-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-021-08687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T11:28:23Z","timestamp":1661340503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12017-021-08687-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["8687"],"URL":"https:\/\/doi.org\/10.1007\/s12017-021-08687-7","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"assertion":[{"value":"26 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of laboratory animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}